Biotechnology News

The global market for Biogas Plants is projected to reach US$10 billion by 2022, driven by the growing focus on alternatives to fossil fuels as a means to achieve energy sustainability and security. Environmental and social benefits of biogas driving its significance as a clean energy source include freeing up of landfills by diverting energy waste streams into fuel; reduced consumption of fossil fuel; helps supplement energy in utility grids and manage intermittent renewable power supply; and cost effective replacement for fossil-sourced natural gas in household heating and cooking applications; lowers water, soil and air pollution; and improved and sustainable management of waste and creation of useful by-products from wastes. Growing environmental footprint of the animal husbandry industry in the form of methane emissions is driving emphasis on the adoption of livestock biogas projec..

Segments covered: Type (Manual, Automated); Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, Other Applications); End-Use (Biotech & Biopharma Companies, Research Institutes, Other End-Uses)Regions covered: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Most R&D budgets which are so vital for innovation are largely dependent upon financial support from governments. Healthy financial performance of companies also determines the extent of willingness to reinvest earnings into R&D and new product development. The COVID-19 induced recession has now cast serious questions on the ability of governments and companies to earmark financial commitments in times of crisis. Academic and industrial research is expected to come under the yoke as immediate focus on surviving the downturn lowers the appetite for both indigenous innovation and international collaboration. Lockdowns imposed in countries worldwide has shutdown laboratories, stifled supply chains and slowed down R&D projects in companies. The modern innovation ecosystem is tightly integrated and interconnected with multiple players in the industry. This close R&D cooperation is expected to..

As a Wiser World Looks to Make a Strong Sustainable Recovery From COVID-19, Synthetic Biology to Receive New Opportunities for Growth. Market to Reach $33.2 Billion. The global market for Synthetic Biology is projected to reach US$33.2 billion by the year 2027, trailing a post COVID-19 CAGR of 25.2%, over the analysis period 2020 through 2027. With humans continuing their mindless plunder of the planet, natural habitat destruction and climate change has already set the stage for an era of pandemics. Animal-borne infectious diseases will continue to rise in the coming years, as human become the new host for displaced animal viruses. The current scenario has amplified the urgency to address environmental issues & ensure strict compliance among polluting businesses. Synthetic biology unfolds a new scientific era, in which synthetic organisms can be created to serve different purposes. Th..

Global Cannabis Testing Market to Reach $2 Billion by 2027Amid the COVID-19 crisis, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at aCAGR of 9.6% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 8.7% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software (Cannabis LIMS) segment is readjusted to a revised 11.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $314.2 Million, While China is Forecast to Grow at 9% CAGRThe Cannabis Testing market in the U.S. is estimated at US$314.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a project..

Global Proteomics Market to Reach $36.6 Billion by 2027Amid the COVID-19 crisis, the global market for Proteomics estimated at US$18 Billion in the year 2020, is projected to reach a revised size of US$36.6 Billion by 2027, growing at a CAGR of 10.7% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 11.6% CAGR and reach US$27.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 8.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.9 Billion, While China is Forecast to Grow at 14.2% CAGRThe Proteomics market in the U.S. is estimated at US$4.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size..

Global Automated and Rapid Microbiological Tests Market to Reach $7.8 Billion by 2027Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. GC/CRT (Clinical), one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the AISS (Clinical) segment is readjusted to a revised 3.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 8.9% CAGRThe Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$1.4 Billion in the..

Global Bioinformatics Market to Reach $21.5 Billion by 2027Amid the COVID-19 crisis, the global market for Bioinformatics estimated at US$9 Billion in the year 2020, is projected to reach a revised size of US$21.5 Billion by 2027, growing at a CAGR of 13.2% over the analysis period 2020-2027. Knowledge Management Tools, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bioinformatics Platforms segment is readjusted to a revised 14.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 17.3% CAGRThe Bioinformatics market in the U.S. is estimated at US$2.4 Billion in the year 2020. China, the world`s second largest economy, is f..

Global DNA Sequencing Market to Reach $28.8 Billion by 2027Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Diagnostics, one of the segments analyzed in the report, is projected to record a 17.7% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery segment is readjusted to a revised 15.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 16.6% CAGRThe DNA Sequencing market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a pr..

Global Biologics Safety Testing Market to Reach $3.3 Billion by 2027Amid the COVID-19 crisis, the global market for Biologics Safety Testing estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 8.5% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$963.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 9.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $556.7 Million, While China is Forecast to Grow at 8% CAGRThe Biologics Safety Testing market in the U.S. is estimated at US$556.7 Million in the year 2020. China, the world`s second largest econo..

Global Nanobiotechnology Market to Reach $100.8 Billion by 2027Amid the COVID-19 crisis, the global market for Nanobiotechnology estimated at US$62.3 Billion in the year 2020, is projected to reach a revised size of US$100.8 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$68.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Medical Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.The U.S. Market is Estimated at $18.4 Billion, While China is Forecast to Grow at 6.6% CAGRThe Nanobiotechnology market in the U.S. is estimated at US$18.4 Billion in the year 2020. China, the world`s second largest econom..

Global Epigenetics Market to Reach $25.6 Billion by 2027Amid the COVID-19 crisis, the global market for Epigenetics estimated at US$7.4 Billion in the year 2020, is projected to reach a revised size of US$25.6 Billion by 2027, growing at a CAGR of 19.5% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 19.9% CAGR and reach US$10.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 22.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 18.8% CAGRThe Epigenetics market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size o..

Global Non-ionizing Radiation/EMF Detection, Measurement, and Safety Market to Reach US$77.1 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Non-ionizing Radiation/EMF Detection, Measurement, and Safety estimated at US$57.2 Billion in the year 2020, is projected to reach a revised size of US$77.1 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.Personal Monitoring Devices, one of the segments analyzed in the report, is projected to grow at a 4.7% CAGR to reach US$24 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Handheld Monitoring Devices segment is readjusted to a revised 4.3% CAGR for the next 7-year period. This segment currently accounts for a 53.4% share of the global Non-ionizing Radiation/EMF Detection, Measurement, a..

Global Microbiome Sequencing Services Market to Reach US$2.9 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Microbiome Sequencing Services estimated at US$931.8 Million in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 17.8% over the analysis period 2020-2027.Synthesis, one of the segments analyzed in the report, is projected to grow at a 16.6% CAGR to reach US$1.3 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ligation segment is readjusted to a revised 14.6% CAGR for the next 7-year period. This segment currently accounts for a 20.4% share of the global Microbiome Sequencing Services market.The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 17.2% CAG..

Global Label-free Array Systems Market to Reach US$1.8 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Label-free Array Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is projected to grow at a 5.5% CAGR to reach US$1.3 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-layer Interferometry (BLI) segment is readjusted to a revised 4.8% CAGR for the next 7-year period. This segment currently accounts for a 17.1% share of the global Label-free Array Systems market.The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast t..

Global Whole Exome Sequencing Market to Reach $3.5 Billion by 2027Amid the COVID-19 crisis, the global market for Whole Exome Sequencing estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Systems, one of the segments analyzed in the report, is projected to record a 17.5% CAGR and reach US$944.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 21.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $310.8 Million, While China is Forecast to Grow at 18.5% CAGRThe Whole Exome Sequencing market in the U.S. is estimated at US$310.8 Million in the year 2020. China, the world`s second largest economy, is forecast t..

Global Human Microbiome Market to Reach US$964.5 Million by the Year 2027Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027.Acute Diarrhea, one of the segments analyzed in the report, is projected to grow at a 14.9% CAGR to reach US$527 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Obesity segment is readjusted to a revised 12.6% CAGR for the next 7-year period. This segment currently accounts for a 4.7% share of the global Human Microbiome market.The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 13.2% CAGR for the Period of 2020-2027The Huma..

Global Industrial Microbiology Market to Reach US$14.4 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Industrial Microbiology estimated at US$10.5 Billion in the year 2020, is projected to reach a revised size of US$14.4 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027.Pharmaceutical, one of the segments analyzed in the report, is projected to grow at a 4.2% CAGR to reach US$6.6 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Food & Beverage segment is readjusted to a revised 5.3% CAGR for the next 7-year period. This segment currently accounts for a 36.5% share of the global Industrial Microbiology market.The U.S. Accounts for Over 29.4% of Global Market Size in 2020, While China is Forecast to Grow at a 4.3% CAGR for the Pe..

Global Biochips Market to Reach $38.1 Billion by 2027Amid the COVID-19 crisis, the global market for Biochips estimated at US$14.1 Billion in the year 2020, is projected to reach a revised size of US$38.1 Billion by 2027, growing at a CAGR of 15.2% over the analysis period 2020-2027. DNA Chip, one of the segments analyzed in the report, is projected to record a 15.1% CAGR and reach US$13.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Protein Chip segment is readjusted to a revised 16.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 19.3% CAGRThe Biochips market in the U.S. is estimated at US$3.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size o..

Global Agricultural Biotechnology Market to Reach $66.2 Billion by 2027Amid the COVID-19 crisis, the global market for Agricultural Biotechnology estimated at US$35.3 Billion in the year 2020, is projected to reach a revised size of US$66.2 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027. Molecular Diagnostics, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$26.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Tissue Culture segment is readjusted to a revised 10.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $10.5 Billion, While China is Forecast to Grow at 8.7% CAGRThe Agricultural Biotechnology market in the U.S. is estimated at US$10.5 Billion in the year 2020. China, the world`s s..

Global Molecular Cytogenetics Market to Reach $3.1 Billion by 2027Amid the COVID-19 crisis, the global market for Molecular Cytogenetics estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 8.2% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $483.7 Million, While China is Forecast to Grow at 12.5% CAGRThe Molecular Cytogenetics market in the U.S. is estimated at US$483.7 Million in the year 2020. China, the world`s second largest economy, is fo..

Global Life Science Instrumentation Market to Reach US$86.4 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Life Science Instrumentation estimated at US$60.3 Billion in the year 2020, is projected to reach a revised size of US$86.4 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.Research Applications, one of the segments analyzed in the report, is projected to grow at a 5.2% CAGR to reach US$42.5 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Clinical & Diagnostic Applications segment is readjusted to a revised 5.9% CAGR for the next 7-year period. This segment currently accounts for a 33.6% share of the global Life Science Instrumentation market.The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is..

Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1 Billion by 2027Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$717.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $192.2 Million, While China is Forecast to Grow at 6.1% CAGRThe Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US..

Global Biofuel Enzymes Market to Reach $1.6 Billion by 2027Amid the COVID-19 crisis, the global market for Biofuel Enzymes estimated at US$956.7 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027. Amylase, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$629.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cellulase segment is readjusted to a revised 8.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $282.9 Million, While China is Forecast to Grow at 7.2% CAGRThe Biofuel Enzymes market in the U.S. is estimated at US$282.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projec..

Global Biotechnology Market to Reach $832 Billion by 2027Amid the COVID-19 crisis, the global market for Biotechnology estimated at US$469.6 Billion in the year 2020, is projected to reach a revised size of US$832 Billion by 2027, growing at a CAGR of 8.5% over the analysis period 2020-2027. DNA Sequencing Market, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$25.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fermentation Market segment is readjusted to a revised 8.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $126.9 Billion, While China is Forecast to Grow at 11.6% CAGRThe Biotechnology market in the U.S. is estimated at US$126.9 Billion in the year 2020. China, the world`s second largest economy, is forecast..

Global Biologics Market to Reach $505.6 Billion by 2027Amid the COVID-19 crisis, the global market for Biologics estimated at US$292.2 Billion in the year 2020, is projected to reach a revised size of US$505.6 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$187.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood & Blood components segment is readjusted to a revised 7.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $86.5 Billion, While China is Forecast to Grow at 7.6% CAGRThe Biologics market in the U.S. is estimated at US$86.5 Billion in the year 2020. China, the world`s second largest economy, is fo..

Global Microbial Identification Market to Reach US$3.4 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Microbial Identification estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027.Instruments, one of the segments analyzed in the report, is projected to grow at a 3.4% CAGR to reach US$1.4 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 7% CAGR for the next 7-year period. This segment currently accounts for a 34.9% share of the global Microbial Identification market.The U.S. Accounts for Over 29.4% of Global Market Size in 2020, While China is Forecast to Grow at a 4.8% CAGR for the Period of 2..

Global Algae Market to Reach $1.2 Billion by 2027Amid the COVID-19 crisis, the global market for Algae estimated at US$782.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Open Pond Cultivation, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$980.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Raceway Pond Cultivation segment is readjusted to a revised 5.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $211.9 Million, While China is Forecast to Grow at 9.4% CAGRThe Algae market in the U.S. is estimated at US$211.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a project..

Global Biopesticides Market to Reach $7.4 Billion by 2027Amid the COVID-19 crisis, the global market for Biopesticides estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at aCAGR of 12.4% over the period 2020-2027. Microbials, one of the segments analyzed in the report, is projected to record 12.7% CAGR and reach US$5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-Rationals segment is readjusted to a revised 11.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $961.9 Million, While China is Forecast to Grow at 11.9% CAGRThe Biopesticides market in the U.S. is estimated at US$961.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Mesenchymal Stem Cells (MSC) Market to Reach $229 Million by 2027Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.The U.S. Market is Estimated at $50.9 Million, While China is Forecast to Grow at 3.9% CAGRThe Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest ec..

Global Circulating Tumor Cell (CTC) Diagnostics Market to Reach $19 Billion by 2027Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. CTC Enrichment Methods, one of the segments analyzed in the report, is projected to record a 17.8% CAGR and reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTC Detection Methods segment is readjusted to a revised 17% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 16.6% CAGRThe Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$1.8 Bill..

Global Biopharmaceutical Bioseparation Systems Market to Reach $12.6 Billion by 2027Amid the COVID-19 crisis, the global market for Biopharmaceutical Bioseparation Systems estimated at US$7.1 Billion in the year 2020, is projected to reach a revised size of US$12.6 Billion by 2027, growing at aCAGR of 8.4% over the period 2020-2027. Chromatography, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$6.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Technologies segment is readjusted to a revised 8.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 12.6% CAGRThe Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$1.9 Billion in the year 2020. Ch..

Global PEGylated Proteins Market to Reach US$1.7 Billion by the Year 2027Amid the COVID-19 crisis, the global market for PEGylated Proteins estimated at US$903.9 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 9.1% over the period 2020-2027.Consumables, one of the segments analyzed in the report, is projected to grow at a 8.5% CAGR to reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 10.4% CAGR for the next 7-year period. This segment currently accounts for a 29.9% share of the global PEGylated Proteins market.The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 8.5% CAGR for the Period of 2020-2027The PEGylated P..

Global Stem Cells Market to Reach $15.1 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 6.9% CAGRThe Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Primary Cells Market to Reach US$1.3 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Primary Cells estimated at US$775.5 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 7.1% over the period 2020-2027.Human Primary Cells, one of the segments analyzed in the report, is projected to grow at a 7.5% CAGR to reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Animal Primary Cells segment is readjusted to a revised 5.7% CAGR for the next 7-year period. This segment currently accounts for a 21.6% share of the global Primary Cells market.The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 6.6% CAGR for the Period of 2020-2027The Primary C..

Global Tangential Flow Filtration Market to Reach $1.7 Billion by 2027Amid the COVID-19 crisis, the global market for Tangential Flow Filtration estimated at US$773 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 11.9% over the analysis period 2020-2027. Regenerated Cellulose, one of the segments analyzed in the report, is projected to record a 11.6% CAGR and reach US$648.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polyethersulfone segment is readjusted to a revised 12.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $228 Million, While China is Forecast to Grow at 11.4% CAGRThe Tangential Flow Filtration market in the U.S. is estimated at US$228 Million in the year 2020. China, the world`s s..

Global Competent Cells Market to Reach $3 Billion by 2027Amid the COVID-19 crisis, the global market for Competent Cells estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $490.7 Million, While China is Forecast to Grow at 8.2% CAGRThe Competent Cells market in the U.S. is estimated at US$490.7 Million in the year 2020. China, the world`s second largest economy, is forecast to rea..

Global Stem Cell Assay Market to Reach $3.4 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cell Assay estimated at US$932.2 Million in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 20.1% over the analysis period 2020-2027. Viability/Cytotoxicity, one of the segments analyzed in the report, is projected to record a 22.4% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Isolation & Purification segment is readjusted to a revised 18.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $276.8 Million, While China is Forecast to Grow at 19.2% CAGRThe Stem Cell Assay market in the U.S. is estimated at US$276.8 Million in the year 2020. China, the world`s second largest econom..

Global Biobanks Market to Reach $74.1 Billion by 2027Amid the COVID-19 crisis, the global market for Biobanks estimated at US$55.3 Billion in the year 2020, is projected to reach a revised size of US$74.1 Billion by 2027, growing at aCAGR of 4.3% over the period 2020-2027. Physical/Real Biobanks, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$48.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Virtual Biobanks segment is readjusted to a revised 3.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $16.3 Billion, While China is Forecast to Grow at 4.1% CAGRThe Biobanks market in the U.S. is estimated at US$16.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Metabolomics Market to Reach $3.5 Billion by 2027Amid the COVID-19 crisis, the global market for Metabolomics estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 12.8% over the analysis period 2020-2027. Bioanalytical Instruments & Equipment, one of the segments analyzed in the report, is projected to record a 11% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metabolomics Applications segment is readjusted to a revised 14.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $443.3 Million, While China is Forecast to Grow at 12.4% CAGRThe Metabolomics market in the U.S. is estimated at US$443.3 Million in the year 2020. China, the world`s second largest eco..

Global Stem Cell Services Market to Reach $41.9 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cell Services estimated at US$17.7 Billion in the year 2020, is projected to reach a revised size of US$41.9 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Service Based, one of the segments analyzed in the report, is projected to record a 13.3% CAGR and reach US$15 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Therapeutic Application segment is readjusted to a revised 14% CAGR for the next 7-year period.The U.S. Market is Estimated at $5.2 Billion, While China is Forecast to Grow at 12.6% CAGRThe Stem Cell Services market in the U.S. is estimated at US$5.2 Billion in the year 2020. China, the world`s second largest economy, is f..

Global Single-use Bioprocessing Market to Reach $10.4 Billion by 2027Amid the COVID-19 crisis, the global market for Single-use Bioprocessing estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$10.4 Billion by 2027, growing at a CAGR of 17.5% over the analysis period 2020-2027. Media Bags & Containers, one of the segments analyzed in the report, is projected to record a 18.5% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Filtration Assemblies segment is readjusted to a revised 17.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $994.5 Million, While China is Forecast to Grow at 16.8% CAGRThe Single-use Bioprocessing market in the U.S. is estimated at US$994.5 Million in the year 2020. China, the worl..

Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Microarray, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$754.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PCR segment is readjusted to a revised 13.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12.6% CAGRThe RNA Analysis/Transcriptomics market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest econ..

Global Protein Binding Assays Market to Reach $514.1 Million by 2027Amid the COVID-19 crisis, the global market for Protein Binding Assays estimated at US$275.2 Million in the year 2020, is projected to reach a revised size of US$514.1 Million by 2027, growing at a CAGR of 9.3% over the analysis period 2020-2027. Equilibrium Dialysis, one of the segments analyzed in the report, is projected to record a 10% CAGR and reach US$205.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ultrafiltration segment is readjusted to a revised 8.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $81.6 Million, While China is Forecast to Grow at 8.7% CAGRThe Protein Binding Assays market in the U.S. is estimated at US$81.6 Million in the year 2020. China, the world`s second large..

Global Polymerase Chain Reaction Market to Reach $11 Billion by 2027Amid the COVID-19 crisis, the global market for Polymerase Chain Reaction estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$11 Billion by 2027, growing at aCAGR of 5% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Consumables segment is readjusted to a revised 5% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 7.7% CAGRThe Polymerase Chain Reaction market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is fore..

Global Plasma Fractionation Market to Reach $31.9 Billion by 2027Amid the COVID-19 crisis, the global market for Plasma Fractionation estimated at US$22.1 Billion in the year 2020, is projected to reach a revised size of US$31.9 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Intravenous Immunoglobulins, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$10.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Coagulation Factor Concentrates segment is readjusted to a revised 6.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $6.5 Billion, While China is Forecast to Grow at 5% CAGRThe Plasma Fractionation market in the U.S. is estimated at US$6.5 Billion in the year 2020. China, the world`s se..

Global Nucleic Acid Labeling Market to Reach $2.8 Billion by 2027Amid the COVID-19 crisis, the global market for Nucleic Acid Labeling estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at aCAGR of 7.3% over the period 2020-2027. Reagents & Kits, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 6.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $508.6 Million, While China is Forecast to Grow at 6.8% CAGRThe Nucleic Acid Labeling market in the U.S. is estimated at US$508.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reac..

Global NGS-based RNA-seq Market to Reach $5.3 Billion by 2027Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $438 Million, While China is Forecast to Grow at 19.3% CAGRThe NGS-based RNA-seq market in the U.S. is estimated at US$438 Million in the year 2020. China, the world`s sec..

Global Neuroscience Antibodies and Assays Market to Reach $5.1 Billion by 2027Amid the COVID-19 crisis, the global market for Neuroscience Antibodies and Assays estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 9.2% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $831.1 Million, While China is Forecast to Grow at 8.2% CAGRThe Neuroscience Antibodies and Assays market in the U.S. is estimated at US$831.1 Million in the year 2020. China, the world`s secon..

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $4.3 Billion by 2027Amid the COVID-19 crisis, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 11.1% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Screening segment is readjusted to a revised 10.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $642.4 Million, While China is Forecast to Grow at 9.7% CAGRThe Isothermal Nucleic Acid Amplification Technology (INAAT) ma..

Global Biodefense Market to Reach US$19.5 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13.5 Billion in the year 2020, is projected to reach a revised size of US$19.5 Billion by 2027, growing at a CAGR of 5.4% over the period 2020-2027.Vaccines, one of the segments analyzed in the report, is projected to grow at a 5.6% CAGR to reach US$12.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biothreat Detection Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 37.1% share of the global Biodefense market.The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5% CAGR for the Period of 2020-2027The Biodefense market in..

Global Biophotonics Market to Reach $100.2 Billion by 2027Amid the COVID-19 crisis, the global market for Biophotonics estimated at US$51.1 Billion in the year 2020, is projected to reach a revised size of US$100.2 Billion by 2027, growing at a CAGR of 10.1% over the analysis period 2020-2027. Tests & Components, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$20.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Medical Therapeutics segment is readjusted to a revised 9.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $15.2 Billion, While China is Forecast to Grow at 9.5% CAGRThe Biophotonics market in the U.S. is estimated at US$15.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to..

Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2027Amid the COVID-19 crisis, the global market for Commercial Biotechnology Separation Systems estimated at US$24.5 Billion in the year 2020, is projected to reach a revised size of US$31 Billion by 2027, growing at a CAGR of 3.4% over the analysis period 2020-2027. DNA Microarray, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$7.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid Chromatography segment is readjusted to a revised 2.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $6.6 Billion, While China is Forecast to Grow at 6.8% CAGRThe Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.6 Bill..

Global Apoptosis Market to Reach $6.9 Billion by 2027Amid the COVID-19 crisis, the global market for Apoptosis estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Assay Kits, one of the segments analyzed in the report, is projected to record a 8.9% CAGR and reach US$2.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 9.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 8.1% CAGRThe Apoptosis market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1...

Global BioImaging Technologies Market to Reach $64.4 Billion by 2027Amid the COVID-19 crisis, the global market for BioImaging Technologies estimated at US$41.1 Billion in the year 2020, is projected to reach a revised size of US$64.4 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Medical Imaging, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$43.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Modular Imaging segment is readjusted to a revised 5.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $12.1 Billion, While China is Forecast to Grow at 6.2% CAGRThe BioImaging Technologies market in the U.S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is f..

Global Fermenters Market to Reach $1.9 Billion by 2027Amid the COVID-19 crisis, the global market for Fermenters estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027. Food, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$600.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Beverages segment is readjusted to a revised 7.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $320.4 Million, While China is Forecast to Grow at 10.8% CAGRThe Fermenters market in the U.S. is estimated at US$320.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of..

Global Genome Editing/Genome Engineering Market to Reach $10.3 Billion by 2027Amid the COVID-19 crisis, the global market for Genome Editing/Genome Engineering estimated at US$4.1 Billion in the year 2020, is projected to reach a revised size of US$10.3 Billion by 2027, growing at a CAGR of 14% over the analysis period 2020-2027. CRISPR, one of the segments analyzed in the report, is projected to record a 14.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the TALEN segment is readjusted to a revised 14.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 13.4% CAGRThe Genome Editing/Genome Engineering market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second l..

Global Genomics Market to Reach $31.5 Billion by 2027Amid the COVID-19 crisis, the global market for Genomics estimated at US$17.5 Billion in the year 2020, is projected to reach a revised size of US$31.5 Billion by 2027, growing at a CAGR of 8.8% over the analysis period 2020-2027. Instruments/Systems, one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$9.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 9.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $5.2 Billion, While China is Forecast to Grow at 8.2% CAGRThe Genomics market in the U.S. is estimated at US$5.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Genotyping Market to Reach $46.4 Billion by 2027Amid the COVID-19 crisis, the global market for Genotyping estimated at US$13.9 Billion in the year 2020, is projected to reach a revised size of US$46.4 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Polymerase Chain Reaction (PCR), one of the segments analyzed in the report, is projected to record a 18.6% CAGR and reach US$16.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing segment is readjusted to a revised 19.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 18.4% CAGRThe Genotyping market in the U.S. is estimated at US$4.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reac..

Global Expression Vectors Market to Reach $415.7 Million by 2027Amid the COVID-19 crisis, the global market for Expression Vectors estimated at US$291.4 Million in the year 2020, is projected to reach a revised size of US$415.7 Million by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. Bacterial Expression Vectors, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$228.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mammalian Expression Vectors segment is readjusted to a revised 6% CAGR for the next 7-year period.The U.S. Market is Estimated at $85.9 Million, While China is Forecast to Grow at 5% CAGRThe Expression Vectors market in the U.S. is estimated at US$85.9 Million in the year 2020. China, the world`s second..

Global Environmental Control Systems Market to Reach $4.8 Billion by 2027Amid the COVID-19 crisis, the global market for Environmental Control Systems estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$4.8 Billion by 2027, growing at aCAGR of 4.2% over the period 2020-2027. Rotary, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fixed segment is readjusted to a revised 3.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 3.9% CAGRThe Environmental Control Systems market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast..

Global High-Resolution Melting Analysis Market to Reach $337.8 Million by 2027Amid the COVID-19 crisis, the global market for High-Resolution Melting Analysis estimated at US$276.2 Million in the year 2020, is projected to reach a revised size of US$337.8 Million by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027. SNP Genotyping, one of the segments analyzed in the report, is projected to record a 2.8% CAGR and reach US$92.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mutation Discovery segment is readjusted to a revised 2.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $81.2 Million, While China is Forecast to Grow at 2.8% CAGRThe High-Resolution Melting Analysis market in the U.S. is estimated at US$81.2 Million in the year 2020. Chin..

Global Drug Discovery Informatics Market to Reach $3.8 Billion by 2027Amid the COVID-19 crisis, the global market for Drug Discovery Informatics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Docking segment is readjusted to a revised 8.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $591.8 Million, While China is Forecast to Grow at 9.2% CAGRThe Drug Discovery Informatics market in the U.S. is estimated at US$591.8 Million in the year 2020. China, the world`s s..

Global Computational Biology Market to Reach $9.2 Billion by 2027Amid the COVID-19 crisis, the global market for Computational Biology estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at a CAGR of 19.2% over the analysis period 2020-2027. Cellular & Biological Simulation, one of the segments analyzed in the report, is projected to record a 18.1% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery & Disease Modelling segment is readjusted to a revised 18.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $798.4 Million, While China is Forecast to Grow at 18.5% CAGRThe Computational Biology market in the U.S. is estimated at US$798.4 Million in the year 2020. Chin..

Global Assisted Reproductive Technology Market to Reach $43.9 Billion by 2027Amid the COVID-19 crisis, the global market for Assisted Reproductive Technology estimated at US$24.7 Billion in the year 2020, is projected to reach a revised size of US$43.9 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$27 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Artificial Insemination-Intrauterine Insemination (AI-IUI) segment is readjusted to a revised 8.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $7.3 Billion, While China is Forecast to Grow at 8% CAGRThe Assisted Reproductive Technology market in the U.S. is estim..

Global Animal Genetics Market to Reach $7.4 Billion by 2027Amid the COVID-19 crisis, the global market for Animal Genetics estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Live Animals, one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Materials segment is readjusted to a revised 6.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 6.5% CAGRThe Animal Genetics market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a pro..

Global Agrigenomics Market to Reach $17.4 Billion by 2027Amid the COVID-19 crisis, the global market for Agrigenomics estimated at US$11.3 Billion in the year 2020, is projected to reach a revised size of US$17.4 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Crops, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$13.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Livestock segment is readjusted to a revised 5.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 6% CAGRThe Agrigenomics market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Bi..

Global Moving Bed Bioreactor (MBBR) Market to Reach $6.2 Billion by 2027Amid the COVID-19 crisis, the global market for Moving Bed Bioreactor (MBBR) estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 19% over the analysis period 2020-2027. Biochemical Oxygen Demand (BOD) / COD Removal, one of the segments analyzed in the report, is projected to record a 19.8% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nitrification/De-Nitrification segment is readjusted to a revised 18.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $494.8 Million, While China is Forecast to Grow at 24.4% CAGRThe Moving Bed Bioreactor (MBBR) market in the U.S. is estimated at US$494.8 Mi..

Global Cell Separation Technologies Market to Reach $5.2 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Separation Technologies estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Research Laboratories & Institutes, one of the segments analyzed in the report, is projected to record a 7.7% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biotechnology & Pharmaceutical Industries segment is readjusted to a revised 9.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $900.5 Million, While China is Forecast to Grow at 7.6% CAGRThe Cell Separation Technologies market in the U.S. is estimated at US$900.5 Millio..

Global Cell Viability Assays Market to Reach $4.7 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Viability Assays estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at aCAGR of 7% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6% CAGR for the next 7-year period.The U.S. Market is Estimated at $864.6 Million, While China is Forecast to Grow at 6.5% CAGRThe Cell Viability Assays market in the U.S. is estimated at US$864.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a pro..

Global Cell Based Assays Market to Reach $24.2 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Based Assays estimated at US$15.2 Billion in the year 2020, is projected to reach a revised size of US$24.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$10.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.5 Billion, While China is Forecast to Grow at 6.4% CAGRThe Cell Based Assays market in the U.S. is estimated at US$4.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach..

Global Cell Counting Market to Reach $12.9 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Counting estimated at US$8.9 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at aCAGR of 5.4% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 6.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 5% CAGRThe Cell Counting market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US..

Global Cell Dissociation Market to Reach $546 Million by 2027Amid the COVID-19 crisis, the global market for Cell Dissociation estimated at US$245.2 Million in the year 2020, is projected to reach a revised size of US$546 Million by 2027, growing at a CAGR of 12.1% over the analysis period 2020-2027. Enzymatic Dissociation Products, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$277.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-enzymatic Dissociation Products segment is readjusted to a revised 11.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $72.4 Million, While China is Forecast to Grow at 11.6% CAGRThe Cell Dissociation market in the U.S. is estimated at US$72.4 Million in the year 2020. China, the wor..

Global Cell Expansion Market to Reach $27.9 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Expansion estimated at US$11.4 Billion in the year 2020, is projected to reach a revised size of US$27.9 Billion by 2027, growing at a CAGR of 13.6% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$10 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 14.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.4 Billion, While China is Forecast to Grow at 13.2% CAGRThe Cell Expansion market in the U.S. is estimated at US$3.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a proje..

Global Cell Line Development Market to Reach $10.7 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Line Development estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027. Equipment, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$4.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Media segment is readjusted to a revised 12.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 11.8% CAGRThe Cell Line Development market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is f..

Global Biotechnology/Pharmaceutical Services Outsourcing Market to Reach $90.9 Billion by 2027Amid the COVID-19 crisis, the global market for Biotechnology/Pharmaceutical Services Outsourcing estimated at US$54.8 Billion in the year 2020, is projected to reach a revised size of US$90.9 Billion by 2027, growing at a CAGR of 7.5% over the analysis period 2020-2027. Consulting Services, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$20.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Auditing & Assessment segment is readjusted to a revised 6.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $14.8 Billion, While China is Forecast to Grow at 11.5% CAGRThe Biotechnology/Pharmaceutical Services Outsourcing market in the U...